Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention? - PubMed (original) (raw)
Review
doi: 10.1038/gt.2010.164. Epub 2011 Jan 6.
Affiliations
- PMID: 21209624
- DOI: 10.1038/gt.2010.164
Review
Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention?
S P Kalra. Gene Ther. 2011 Apr.
Abstract
The incidence of diabetes mellitus has soared to epidemic proportion worldwide. The debilitating chronic hyperglycemia is caused by either lack of insulin as in diabetes type 1 or its ineffectiveness as in diabetes type 2. Frequent replacement of insulin with or without insulin analogs for optimum glycemic control are the conventional cumbersome therapies. Recent application of leptin gene transfer technology has uncovered the participation of adipocytes-derived leptin-dependent hypothalamic neural signaling in glucose homeostasis and demonstrated that a breakdown in this communication due to leptin insufficiency in the hypothalamus underlies the etiology of chronic hyperglycemia. Reinstatement of central leptin sufficiency by hyperleptinemia produced either by intravenous leptin infusion or a single systemic injection of recombinant adenovirus vector encoding leptin gene suppressed hyperglycemia and evoked euglycemia only transiently in rodent models of diabetes type 1. In contrast, stable restoration of leptin sufficiency, solely in the hypothalamus, with biologically active leptin transduced by an intracerebroventicular injection of recombinant adeno-associated virus vector encoding leptin gene (rAAV-lep) abolished hyperglycemia and imposed euglycemia through the extended duration of experiment by stimulating glucose disposal in the periphery in models of diabetes type 1. Further, similar hypothalamic leptin transgene expression abrogated chronic hyperglycemia and hyperinsulinemia, the predisposing risk factors of the age and environmentally acquired diabetes type 2, and instituted euglycemia by independently activating relays that stimulate glucose metabolism and repress hyperinsulinemia and improve insulin sensitivity in the periphery. Consequently, this durable antidiabetic efficacy of one time rAAV-lep neurotherapy offers a potential novel substitute for insulin therapy following preclinical trials in subhuman primates and humans.
Similar articles
- Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
Kojima S, Asakawa A, Amitani H, Sakoguchi T, Ueno N, Inui A, Kalra SP. Kojima S, et al. Peptides. 2009 May;30(5):962-6. doi: 10.1016/j.peptides.2009.01.007. Epub 2009 Jan 22. Peptides. 2009. PMID: 19428774 - Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice.
Ueno N, Inui A, Kalra PS, Kalra SP. Ueno N, et al. Peptides. 2006 Sep;27(9):2332-42. doi: 10.1016/j.peptides.2006.03.006. Epub 2006 Apr 18. Peptides. 2006. PMID: 16621153 - Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.
Boghossian S, Ueno N, Dube MG, Kalra P, Kalra S. Boghossian S, et al. Neurobiol Aging. 2007 Oct;28(10):1594-604. doi: 10.1016/j.neurobiolaging.2006.08.010. Epub 2006 Sep 29. Neurobiol Aging. 2007. PMID: 17011078 - Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation.
Kalra SP. Kalra SP. Peptides. 2009 Oct;30(10):1957-63. doi: 10.1016/j.peptides.2009.07.021. Epub 2009 Aug 6. Peptides. 2009. PMID: 19647774 Free PMC article. Review. - Neuroendocrine control of energy homeostasis: update on new insights.
Kalra SP, Kalra PS. Kalra SP, et al. Prog Brain Res. 2010;181:17-33. doi: 10.1016/S0079-6123(08)81002-3. Prog Brain Res. 2010. PMID: 20478430 Review.
Cited by
- A case for new therapy for diabetes, is it leptin?
Kalra SP. Kalra SP. Indian J Endocrinol Metab. 2012 Dec;16(Suppl 3):S525-8. doi: 10.4103/2230-8210.105566. Indian J Endocrinol Metab. 2012. PMID: 23565484 Free PMC article. No abstract available. - Effects of a Ruthenium Schiff Base Complex on Glucose Homeostasis in Diet-Induced Pre-Diabetic Rats.
Mabuza LP, Gamede MW, Maikoo S, Booysen IN, Ngubane PS, Khathi A. Mabuza LP, et al. Molecules. 2018 Jul 14;23(7):1721. doi: 10.3390/molecules23071721. Molecules. 2018. PMID: 30011905 Free PMC article. - The role of leptin in the control of insulin-glucose axis.
Amitani M, Asakawa A, Amitani H, Inui A. Amitani M, et al. Front Neurosci. 2013 Apr 8;7:51. doi: 10.3389/fnins.2013.00051. eCollection 2013. Front Neurosci. 2013. PMID: 23579596 Free PMC article. - Benefits of leptin therapy in HIV patients.
Sinha U, Sinharay K, Sengupta N, Mukhopadhyay P. Sinha U, et al. Indian J Endocrinol Metab. 2012 Dec;16(Suppl 3):S637-43. doi: 10.4103/2230-8210.105583. Indian J Endocrinol Metab. 2012. PMID: 23565500 Free PMC article. - Central nervous control of energy and glucose balance: focus on the central melanocortin system.
Xu Y, Elmquist JK, Fukuda M. Xu Y, et al. Ann N Y Acad Sci. 2011 Dec;1243:1-14. doi: 10.1111/j.1749-6632.2011.06248.x. Ann N Y Acad Sci. 2011. PMID: 22211889 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous